Compare · INGN vs ISRG
INGN vs ISRG
Side-by-side comparison of Inogen Inc (INGN) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INGN and ISRG operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $149.48B, about 861.3x INGN ($173.5M).
- ISRG has been more active in the news (7 items in the past 4 weeks vs 2 for INGN).
- ISRG has more recent analyst coverage (25 ratings vs 11 for INGN).
- Company
- Inogen Inc
- Intuitive Surgical Inc.
- Price
- $6.41+1.26%
- $422.09+0.78%
- Market cap
- $173.5M
- $149.48B
- 1M return
- -10.04%
- -
- 1Y return
- -3.61%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2014
- 2000
- News (4w)
- 2
- 7
- Recent ratings
- 11
- 25
Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest INGN
- EVP Entrprs Enblmnt, Ch HR Off Yi Boyer Jennifer M sold $70,313 worth of shares (10,770 units at $6.53) as part of a pre-agreed trading plan, decreasing direct ownership by 40% to 15,977 units (SEC Form 4)
- SEC Form SD filed by Inogen Inc
- SEC Form 10-Q filed by Inogen Inc
- Inogen Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Inogen Announces First Quarter 2026 Financial Results
- SEC Form S-8 filed by Inogen Inc
- SEC Form DEF 14A filed by Inogen Inc
- Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
- SEC Form PRE 14A filed by Inogen Inc
- SEC Form 4 filed by Richardson Jason Andrew
Latest ISRG
- SVP & GM da Vinci Platforms & Jeddi Iman sold $2,365,594 worth of shares (5,625 units at $420.55) as part of a pre-agreed trading plan and exercised 5,625 shares at a strike of $77.00 (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $15,945 worth of shares (36 units at $442.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,523 units (SEC Form 4)
- SEC Form SD filed by Intuitive Surgical Inc.
- Intuitive Announces Innovations to Advance Quintuple Aim
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $23,464 worth of shares (54 units at $434.52) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,559 units (SEC Form 4)
- EVP & Chief Legal and Complian Loeb Gary sold $178,780 worth of shares (400 units at $446.95) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 6,120 units (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by Director Guthart Gary S